Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Randomized Controlled Trial"
journalStr:"Breast cancer research and treatment"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (122)
1
Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)
enthalten in:
Breast cancer research and treatment
| 2023
von
Hwang, I.
|
Kim, J.
|
Jeong, J.
| +8
Wird geladen...
2
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
enthalten in:
Breast cancer research and treatment
| 2023
von
Iwata, H.
|
Yamamoto, Y.
|
Sakai, T.
| +12
Wird geladen...
3
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN) : final analysis of a phase III, randomized, double-blind, placebo-controlled study
enthalten in:
Breast cancer research and treatment
| 2023
von
Xu, B.
|
Li, W.
|
Zhang, Q.
| +11
Wird geladen...
4
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer : primary results from cohort B of the IPATunity130 randomized phase 3 trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Turner, N.
|
Dent, R.
|
O'Shaughnessy, J.
| +13
Wird geladen...
5
Analysis of the pan-Asian subgroup of patients in the NALA Trial : a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
enthalten in:
Breast cancer research and treatment
| 2021
von
Dai, M.
|
Feng, Y.
|
Chen, S.
| +23
Wird geladen...
6
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer : final results from a randomized phase III trial
enthalten in:
Breast cancer research and treatment
| 2021
von
Stebbing, J.
|
Baranau, Y.
|
Baryash, V.
| +11
Wird geladen...
7
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
enthalten in:
Breast cancer research and treatment
| 2021
von
Huang, C.
|
Yang, Y.
|
Kwong, A.
| +10
Wird geladen...
8
Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer : the Canadian Cancer Trials Group (CCTG) MA.21 experience
enthalten in:
Breast cancer research and treatment
| 2020
von
Dent, S.
|
Botros, J.
|
Rushton, M.
| +8
Wird geladen...
9
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease : a joint analysis of PALOMA-2 and PALOMA-3 clinical trials
enthalten in:
Breast cancer research and treatment
| 2020
von
Finn, R.
|
Cristofanilli, M.
|
Ettl, J.
| +11
Wird geladen...
10
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN) : a phase III, randomized, double-blind, placebo-controlled study
enthalten in:
Breast cancer research and treatment
| 2020
von
Xu, B.
|
Li, W.
|
Zhang, Q.
| +11
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Randomized Controlled Trial
Filter aufheben
Zeitschrift: Breast cancer research and treatment
Medienart
122
Aufsätze
105
E-Artikel
105
E-Ressourcen
17
Gedruckte Aufsätze
Zeitschriftentitel
Breast cancer research and treatment
Thema
122
Clinical Trial, Phase III
122
Journal Article
Randomized Controlled Trial
56
Multicenter Study
55
Research Support, Non-U.S. Gov't
30
EC 2.7.10.1
29
Receptor, ErbB-2
27
Antineoplastic Agents, Hormonal
25
Breast cancer
23
094ZI81Y45
23
Tamoxifen
21
Fluorouracil
21
Letrozole
21
Nitriles
21
Receptors, Estrogen
21
Triazoles
21
U3P01618RT
20
7LKK855W8I
20
Comparative Study
19
15H5577CQD
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
113
2000-
4
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
122
Englisch
Haven't found what you're looking for?
Wird geladen...